SE421426B - Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion - Google Patents

Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion

Info

Publication number
SE421426B
SE421426B SE7605927A SE7605927A SE421426B SE 421426 B SE421426 B SE 421426B SE 7605927 A SE7605927 A SE 7605927A SE 7605927 A SE7605927 A SE 7605927A SE 421426 B SE421426 B SE 421426B
Authority
SE
Sweden
Prior art keywords
isopropylendioxy
16alfa
17alfa
crystallinic
11beta
Prior art date
Application number
SE7605927A
Other languages
English (en)
Other versions
SE7605927L (sv
Inventor
J H Fried
R E Jones
G T Haringer
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7605927L publication Critical patent/SE7605927L/sv
Publication of SE421426B publication Critical patent/SE421426B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
SE7605927A 1975-05-27 1976-05-25 Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion SE421426B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (2)

Publication Number Publication Date
SE7605927L SE7605927L (sv) 1976-11-28
SE421426B true SE421426B (sv) 1981-12-21

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605927A SE421426B (sv) 1975-05-27 1976-05-25 Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion

Country Status (15)

Country Link
JP (1) JPS51144719A (sv)
AT (1) AT357702B (sv)
AU (1) AU506080B2 (sv)
CA (1) CA1075228A (sv)
DE (2) DE2661037C2 (sv)
ES (1) ES448220A1 (sv)
FR (1) FR2361900A1 (sv)
GB (1) GB1525181A (sv)
HK (1) HK8580A (sv)
IL (1) IL49652A (sv)
MX (1) MX3864E (sv)
MY (1) MY8000275A (sv)
NL (1) NL191234C (sv)
NZ (1) NZ180946A (sv)
SE (1) SE421426B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162530C (da) * 1979-05-21 1992-03-30 Syntex Corp Fremgangsmaade til fremstilling af en krystallinsk modifikation af flunisolid
ATE3774T1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
HU209603B (en) * 1988-10-05 1994-09-28 Upjohn Co Process for production of solid powders in finalydivided microcristallin form
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
ES2183001T3 (es) * 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
AU766410B2 (en) * 1999-03-03 2003-10-16 Optinose As Nasal delivery device
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CA2905587A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
GB933867A (en) * 1958-12-08 1963-08-14 American Cyanamid Co Fluorinated steroids
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) * 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
MY8000275A (en) 1980-12-31
MX3864E (es) 1981-08-26
JPS51144719A (en) 1976-12-13
DE2624924A1 (de) 1977-12-15
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
NZ180946A (en) 1978-07-28
FR2361900A1 (fr) 1978-03-17
AU506080B2 (en) 1979-12-13
HK8580A (en) 1980-03-14
SE7605927L (sv) 1976-11-28
DE2624924C2 (de) 1986-11-27
IL49652A0 (en) 1976-07-30
FR2361900B1 (sv) 1979-04-13
GB1525181A (en) 1978-09-20
NL7605699A (nl) 1976-11-30
CA1075228A (en) 1980-04-08
ATA388376A (de) 1979-12-15
DE2661037C2 (sv) 1989-04-06
AT357702B (de) 1980-07-25
NL191234C (nl) 1995-04-03
NL191234B (nl) 1994-11-01
AU1430176A (en) 1977-12-01
JPS6247880B2 (sv) 1987-10-09

Similar Documents

Publication Publication Date Title
SE421426B (sv) Sett att framstella en unik kristallinisk polymorf form av alfa-fluor-11beta, 21-dihydroxi-16alfa, 17alfa-isopropylendioxi-1,4-dien-3,20-dion
SE420599B (sv) Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon
SE7607771L (sv) Sett for framstellning av utvidgningsbara perlor
SE445039B (sv) Sett att framstella cement av portlandtyp
SE7602706L (sv) Forfarande for framstellning av oorganisk - organiska plaster
SE422077B (sv) Sett att framstella syntesgas
SE427748B (sv) Forfarande for framstellning av frostherdig betong
SE399574C (sv) Sett for framstellning av fluffmassa
DK554179A (da) Fremgangsmaade til fremstilling af ergolinderivater
SE7611629L (sv) Sett att framstella expanderad slagg
SE437155B (sv) Sett att framstella nya derivat av perhydro-aza-heterocykler
SE7608927L (sv) Sett att framstella pyridinderivat
NO142520C (no) Fremgangsmaate til fremstilling av fleksible sprengstoff-formlegemer
SE413771B (sv) Sett att framstella nya derivat av 5h-dibebs(b,f)azepin
SE7603359L (sv) Sett for direkt framstellning av rastal
SE7903977L (sv) Forfarande for framstellning av konstruktionselement bestaende av gipsskum
SE7607239L (sv) Sett att framstella beta-acylpyrroler
NO144886C (no) Fremgangsmaate til fremstilling av oksiranforbindelser
SE7612886L (sv) Sett vid framstellning av koncentrerade suspensioner
SE420690B (sv) Sett att kontinuerligt framstella vermeisolerande ledningsror
SE420982B (sv) Sett att styra en omformningsprocess jemte anordning for genomforande av settet
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE432926B (sv) Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan
SE7508654L (sv) Forfarande for framstellning av steroider

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7605927-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7605927-8

Format of ref document f/p: F